PILOT TRIAL OF AN ORAL TWICE-DAILY NEW L-VALYL ESTER OF ACYCLOVIR (VALACYCLOVIR) FOR PROPHYLAXIS AGAINST HERPES-SIMPLEX VIRUS (HSV) IN BONE-MARROW TRANSPLANT PERIPHERAL STEM-CELL (BMT) PATIENTS
J. Essell et al., PILOT TRIAL OF AN ORAL TWICE-DAILY NEW L-VALYL ESTER OF ACYCLOVIR (VALACYCLOVIR) FOR PROPHYLAXIS AGAINST HERPES-SIMPLEX VIRUS (HSV) IN BONE-MARROW TRANSPLANT PERIPHERAL STEM-CELL (BMT) PATIENTS, Blood, 90(10), 1997, pp. 2421-2421